Thyrocare Tech.

70
Buy
  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE594H01019
  • NSEID: THYROCARE
  • BSEID: 539871
INR
421.50
-6.6 (-1.54%)
BSENSE

Dec 05

BSE+NSE Vol: 4.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
687.00
571.00
526.00
588.00
494.00
434.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
687.00
571.00
526.00
588.00
494.00
434.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
190.00
166.00
163.00
170.00
163.00
117.00
Power & Fuel Cost
11.00
10.00
10.00
8.00
7.00
8.00
Employee Cost
126.00
107.00
106.00
61.00
58.00
48.00
Operating Expenses
79.00
61.00
58.00
52.00
44.00
32.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
36.00
30.00
19.00
21.00
23.00
23.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
5.00
13.00
12.00
15.00
7.00
9.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
496.00
433.00
404.00
353.00
323.00
260.00
Operating Profit (PBDIT) excl Other Income
191.00
138.00
122.00
235.00
171.00
173.00
Other Income
14.00
9.00
8.00
29.00
12.00
6.00
Operating Profit (PBDIT)
205.00
148.00
130.00
264.00
183.00
180.00
Interest
3.00
5.00
4.00
3.00
0.00
1.00
Profit before Depriciation and Tax
202.00
142.00
126.00
261.00
182.00
178.00
Depreciation
55.00
47.00
38.00
33.00
30.00
31.00
Profit Before Taxation & Exceptional Items
146.00
95.00
87.00
227.00
152.00
146.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
145.00
95.00
88.00
227.00
152.00
140.00
Provision for Tax
54.00
26.00
24.00
51.00
39.00
52.00
Profit After Tax
92.00
69.00
63.00
176.00
113.00
87.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
319.00
343.00
356.00
259.00
201.00
271.00
Profit Available for appropriations
410.00
414.00
421.00
436.00
314.00
359.00
Appropriations
410.00
414.00
421.00
436.00
314.00
359.00
Equity Dividend (%)
210.00%
180.00%
180.00%
150.00%
250.00%
50.00%
Earnings Per Share
17.13
13.42
12.16
33.30
21.41
16.74
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 20.19% vs 8.58% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 37.68% vs 13.25% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -32.37% vs 14.49% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 33.42% vs 9.37% in Mar 2024

Compare Profit and Loss Results of Thyrocare Tech.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
687.00
1,331.00
-644.00
-48.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
687.00
1,331.00
-644.00
-48.38%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
190.00
268.00
-78.00
-29.10%
Power & Fuel Cost
11.00
19.00
-8.00
-42.11%
Employee Cost
126.00
313.00
-187.00
-59.74%
Operating Expenses
79.00
48.00
31.00
64.58%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
36.00
37.00
-1.00
-2.70%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
19.00
-14.00
-73.68%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
496.00
1,022.00
-526.00
-51.47%
Operating Profit (PBDIT) excl Other Income
191.00
308.00
-117.00
-37.99%
Other Income
14.00
15.00
-1.00
-6.67%
Operating Profit (PBDIT)
205.00
323.00
-118.00
-36.53%
Interest
3.00
23.00
-20.00
-86.96%
Profit before Depriciation and Tax
202.00
299.00
-97.00
-32.44%
Depreciation
55.00
108.00
-53.00
-49.07%
Profit Before Taxation & Exceptional Items
146.00
190.00
-44.00
-23.16%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
145.00
190.00
-45.00
-23.68%
Provision for Tax
54.00
45.00
9.00
20.00%
Profit After Tax
92.00
145.00
-53.00
-36.55%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
319.00
888.00
-569.00
-64.08%
Profit Available for appropriations
410.00
1,032.00
-622.00
-60.27%
Appropriations
410.00
1,032.00
-622.00
-60.27%
Equity Dividend (%)
210%
0%
210.00
Earnings Per Share
17.13
28.29
-11.16
-39.45%
Profit And Loss - Net Sales
Net Sales 687.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.19% vs 8.58% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 191.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.68% vs 13.25% in Mar 2024

Profit And Loss - Interest
Interest 3.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -32.37% vs 14.49% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 92.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.42% vs 9.37% in Mar 2024